Psyllid ID: psy5522

Local Sequence Feature Prediction

Prediction and (Method)	Result

Residue Number Marker

Protein Sequence

Secondary Structure (PSIPRED)

Secondary Structure Prediction (SSPRO)

Coil and Loop (DISEMBL)

Flexible Loop (DISEMBL)

Low Complexity Region (SEG)

Disordered region (IsUnstruct)

Disordered Region (DISOPRED)

Disordered Region (DISEMBL)

Disordered Region (DISPRO)

Transmembrane Helix (TMHMM)

Transmembrane Helix (HMMTOP)

Transmembrane Helix (MEMSAT)

TM Helix, Signal Peptide (MEMSAT_SVM)

TM Helix, Signal Peptide (Phobius)

Signal Peptide (SignalP HMM Mode)

Signal Peptide (SignalP NN Mode)

Coiled Coils (COILS)

Positional Conservation

--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------140

YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANVSPDETEPGSNIQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEQLLSQVTTSVTQLTVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPSLQVSQNVKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLESKAHNEDGKKWWKRAERPEDKKNPWAQVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMSKKELCPTVSAFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVIGLYALAQLAEKVLARNNDVSISFKYLNGQSSEMSVNRLNNMILQKNEVYEFHASHF

cEEEEEccEEEcccEEEEEEEEEcccccEEEEEEEEEEcccccEEEEEEEEEEcccEEEEEEEEcccccccEEEEEEEEEcEEEEEEEEEEEEEEEccEEEEEccccccccccEEEEEEEEEcccccccccccEEEEEEcccccEEEEEEEccccccEEEcccccccccccccEEEEEEEccEEEEEEEEEEEEccccEEEEEEccccEEEcccEEEEEEEEEEEccccccEEEEEEEEEEcccccccccccccEEEEEEEccEEEEEEEEEEEEccccccccEEEEEEEEEEccccEEEEEEEEEEEEEEEEEEEEEEccccccccccEEEEEEEEccccccccccccEEEEEEcEEcccccccEEEEEEccccEEEEEEEccccccEEEEEEEEEEcccccEEEEEcccccccccEEEEEEcccccccccEEEEEEEEEccccEEEEEEEEccEEEEEEEEEEcccccEEEEEEEEEcccccEEEEEEEEEEcccEEEEEEEEEEEEcEEcccEEEEEcccccccccEEEEEEEEccccEEEEEEEEcEEEcccccccccHHHHHHHcccccccccccccccccccccccccccccccccccccEEEEccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccEEEEccccccccEEEEEEEEEccccccccccccEEEEEEEEEEEEEEccccEEEccEEEEEEEEEEEccccEEEEEEEEEcccEEEEEcccccccccccccEEEEEEEEEEcccccEEEEEEEEEEEcccEEEEEEEEEccccccEEEEEEEcccccEEEEEEEEEEEcccccEEEEEEEEcccccccccccEEEEEEEccccccccccHHHHHcccccccccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHHcccccccccccccEEEccccccccccEEEHHHHHHHHHccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccEEHHHHccccccccccccccccEEEEEEEEEEccccccccccEEEEEEccccccccccEEEEEEEEcccccccEEEEEEcccccEEEcccccccccccccEEEEEEEcccEEEEEEEEEccccccEEEEcEEcccccccHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHccccccccEEEEEEEEEccccccEEEEcccccccccccccccccHHHHHHHHHHHHHHHHHHccccccEEEEEEccccccccccccHHHHHHHHHcEEEcccccc

cEEEEEccEEccccccEEEEEEEcccccEEEEEEEEEcccccEEEEEEEEEEccccEEEEEEEcccccccccEEEEEEEcccEEEEEEEEEEEEEcccEEEEEcccccEccccEEEEEEEEEcccccccccccEEEEEEcccccEEEEEccccccccEEEccccccccccccEEEEEEEEcccEEEEEEEEEEEEcccEEEEEEcccEEEEEccEEEEEEEEEEEccccccEEEEEEEEcccccccccccccccEEEEEccccEEEEEEEcHHHHHHHHHcccEEEEEEEEEEccccEEEEcccEEEEEEEEEEEEEEEccccccccccEEEEEEEEccccccccccEEEEEEEcccccccccccEEEEEcccccEEEEEEEcccccccEEEEEEEEcccccccEEEEEccccccccEEEEEEcccccccccEEEEEEEEEccccEEEEEEEEcccEEEEcEEEEcccccEEEEEEEccccccccEEEEEEEEEccccEEEccEEEEEEHccccEEEEEEccccccccccEEEEEEEccccEEEEEEEcccEEEEcccccccHHHHHHHHccccccccccccccccccccccccccHHHHHHHcccEEEccccccccccccccccccccHHHHHHcccccccccccccccccHHHcccccEEEEEEEcccccEEEEEEEcccccEEEEEEEEEEccccccEEcccccEEEEEEcEEEEEEccEEEEcccEEEEEEEEEEcccccEEEEEEEEccccEEEEEccccccccccccccccEEEEEEEEcccccEEEEEEEEcccccEEEEEEEEEcccccEEEEEEEEEcccEEEEEEEEEEEEccccccEEEEEEccccccccccccEEEEEEEccHHHHHHHHHHHHccccccccHHHHHHHcccEEHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccEccccccccccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHccccccccccccEHcHcccccccccHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHcccccccccccccccccEEccHccccccHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHcccccEEEEccccccccccccccccccHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccHHcccccEEEEEEccccccccEEEEccccccHcHccccccccccccccHHccccccHHHccccccccccEEEEEcccccHcHHHHHHHHHHcccHHHHHHccc

yytvvapkvlrpngeyHVAVSTQAVSEATQVSVEvggkqdsggefrtkqllsvdpfstrivkldigdlgpgqynltvkgsgslnfynstGLVYVHKSYSVFIQLDkaiykpgdlVRFRAIVLNshlkpsvtGALEIFItdgkgnriKQWTRALTtrgvfsadlqlskspvlgdwnITINVLDQKFTKRFTVAEyvlpkfevnvnvpphatfkdskVVISVNakytygkpvkgeatitayptifsgviqplfqtpvrkvvpidgktviEFDVVkelqltdeyerniHFDVAVEEALtgrrqnntgsvvfHKHKYKMDLiksseyfkpglkYTAYMKlthhdgtpvtdnnnmvqvrhgfsydeskyeanqykldrngmiklvyyppanenvttlgIEAEYLDIKEWFStisasespsnSFIQAALLtqnpkvnkdVELEinstaplkyISYQvlgrgdvimadtitvpgnkMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLelegglqnfvsanvspdetepgsniqinleakpnsyiGLLAVDQKVLLLKtgndigkeDVMRELrsydetdtsklplvenlrerypgsftaqATFEKAGAIVmtngyvhernpwvyykslndppddmldgeEQLLSQVTTSVTQltvrkhfpetwlfqmeetgfdgkvmvnekvpDSITSWVLSAFSvdslyglglmdmpkklrvfrpffisldlpysvmrgEVVAIPVVVFNYLSqdlvadvtlenvgqfdfadfsnevdaapqpkfevFRRKKLtikansgstttfvitpkelgyIGIKVTatsnlagdsmegkllvkpegetqyknKAIFVDLRKNKTFSVNVtldmpknivpgsehvEVSAvgdllgpsipnlanlikmpfgcgeqnmlnfvPNIVVLEYLKKTYQLTDAIEAKASRYLETGyqqeltyrrpdgsfsafgttdpngsTWLTAFVAKSFRQAASHTTIDESVILEALAWLSsnqavngsfpevgkvshadmqggAAKGLALTAYtllpkktravnmtatGSGFAVVYISYQYNinvtgawpmftldpqvdknsdsnhlqlsicsgfigegdsnMAVMEVslpsgftvdsdalpslqvsqNVKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSkyprmntiNKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLleskahnedGKKWWKraerpedkknpwaqvpnsvdvEMTSYALLSYLdrglvedtlPILTWLVTQqndqggfastqmskkelcptvsafrthkvaqqkpvpvsiydyydqsrrarmfyeprvatlcdicegedcskDTVIGLYALAQLAEKVLARNNDVSISFKYLNGQSSEMSVNRLNNMILQKNEVYEFHASHF

yytvvapkvlrpngeYHVAVSTQAVSEATQVSVEVggkqdsggefrtkqllsvdpfsTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLnshlkpsvtgaleifitdgkgnriKQWTRALTTRGVFsadlqlskspvlgdwNITINVLDQKFTKRFTVAEYVLPkfevnvnvpphatfkdskvviSVNAKytygkpvkgeATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKelqltdeyerNIHFDVAVEealtgrrqnntgsvvfhkhkyKMDLIKSSEYFKPGLKYTAYMKLTHHdgtpvtdnnnMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANVSPDETEPGSNIQINLEAKPNSYIGLLAVDQKVLLLKtgndigkedvmrelrsydetdtsklplvenLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEQLLSQVTTSVTQLTVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKkltikansgstttfvitpkelgYIGIKVTatsnlagdsmEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLdmpknivpgsEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPSLQVSQNVKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLEskahnedgkkwwkraerpedkknpwaqvpnsvDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMSKKELCPTVSAFrthkvaqqkpvpvsiYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVIGLYALAQLAEKVLARNNDVSISFKYLNGQSSEMSVNRLNNMILQKNEVYEFHASHF

YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVAdgldlelegglQNFVSANVSPDETEPGSNIQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEqllsqvttsvtqltvRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPSLQVSQNVKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLESKAHNEDGKKWWKRAERPEDKKNPWAQVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMSKKELCPTVSAFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVIGLYALAQLAEKVLARNNDVSISFKYLNGQSSEMSVNRLNNMILQKNEVYEFHASHF

****V**KVLRPNGEYHVAVS*************************TKQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTIS********FIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVS***************INLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVM**************PLVENLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLN************LLSQVTTSVTQLTVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVD*****NHLQLSICSGFIGEGDSNMAVMEVSLPSGFTV*************VKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLES*********WW**************QVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQND************ELCPTVSAFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVIGLYALAQLAEKVLARNNDVSISFKYLNG*******NRLNNMILQKNEVY*******

YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESP*************PKVNKDVELEINSTAPLKYISYQVLGRGDVIMA************VIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANVS*****PGSNIQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEQLLSQVTTSVTQLTVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSN***************KKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLT*AIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPS***********TKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLESKAHNEDGKKWW**************QVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMSKKELCPTVSAFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVI***********************KYLNGQSSEMSVNRLNNMILQKNEVYEFHA***

YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANV********SNIQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEQLLSQVTTSVTQLTVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPSLQVSQNVKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLESKAHNEDGKKWWKRAERPEDKKNPWAQVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMSKKELCPTVSAFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVIGLYALAQLAEKVLARNNDVSISFKYLNGQSSEMSVNRLNNMILQKNEVYEFHASHF

YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYDESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANVSPDETEPGSNIQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYPGSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEQLLSQVTTSVTQLTVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVD*APQ**FEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFTLDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPSLQVSQNVKRVETKNGNTMVVLYFAYHQVLPWTLMHYLVSKYPRMNTINKAVDYIVKNLAGTEDAYAIAICSYALHLAQHPVKDVAFNLLESKAHNEDGKKWWKRAER**DKKNPWAQVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMSKKELCPTVSAFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDTVIGLYALAQLAEK*L*RNNDVSISFKYLNGQSSEMSVNRLNNMILQKNEVYEFHASHF

ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii

iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Alignment graph	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query		1397	2.2.26 [Sep-21-2011]
Q6YHK3		1445	CD109 antigen OS=Homo sap	yes	N/A	0.693	0.670	0.350	1e-162
Q8R422		1442	CD109 antigen OS=Mus musc	yes	N/A	0.648	0.628	0.350	1e-150
Q63041		1500	Alpha-1-macroglobulin OS=	yes	N/A	0.642	0.598	0.301	1e-107
Q5R4N8		1474	Alpha-2-macroglobulin OS=	no	N/A	0.634	0.601	0.300	1e-106
P01023		1474	Alpha-2-macroglobulin OS=	no	N/A	0.639	0.605	0.299	1e-106
Q6IE52		1448	Murinoglobulin-2 OS=Rattu	no	N/A	0.644	0.622	0.293	1e-104
P06238		1472	Alpha-2-macroglobulin OS=	no	N/A	0.652	0.618	0.300	1e-103
Q6GQT1		1474	Alpha-2-macroglobulin-P O	no	N/A	0.654	0.620	0.300	1e-103
P14046		1477	Alpha-1-inhibitor 3 OS=Ra	no	N/A	0.647	0.612	0.295	1e-103
P20740		1473	Ovostatin OS=Gallus gallu	no	N/A	0.652	0.619	0.285	1e-101

>sp\|Q6YHK3\|CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2	Back alignment and function desciption

 Score =  573 bits (1476), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 377/1077 (35%), Positives = 559/1077 (51%), Gaps = 108/1077 (10%)

Query: 2    YTVVAPKVLRPNGEY------------HVAVSTQAVSEATQVSVEVGGKQD--SGGEFRT 47
            + V AP ++RP G               V V  + +  A+ ++V V   +     G F+T
Sbjct: 28   FLVTAPGIIRPGGNVTIGVELLEHCPSQVTVKAELLKTASNLTVSVLEAEGVFEKGSFKT 87

Query: 48   KQLLSVDPFSTRIVKLDIGDLGPGQYNLTVKG--SGSLNFYNSTGLVYVHKSYSVFIQLD 105
              L S+   S   +           Y L V G     + F NST L +  K  SVFIQ D
Sbjct: 88   LTLPSLPLNSADEI-----------YELRVTGRTQDEILFSNSTRLSFETKRISVFIQTD 136

Query: 106  KAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQL 165
            KA+YKP   V+FR + L S  KP  T +L I I D K N I+QW    +  GV S   QL
Sbjct: 137  KALYKPKQEVKFRIVTLFSDFKPYKT-SLNILIKDPKSNLIQQWLSQQSDLGVISKTFQL 195

Query: 166  SKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYT 225
            S  P+LGDW+I + V DQ + + F V+EYVLPKFEV +  P + +     +  ++ AKYT
Sbjct: 196  SSHPILGDWSIQVQVNDQTYYQSFQVSEYVLPKFEVTLQTPLYCSMNSKHLNGTITAKYT 255

Query: 226  YGKPVKGEATITAYPTIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNI 285
            YGKPVKG+ T+T  P  F G      +  + K   I+G     F+        DE  +N+
Sbjct: 256  YGKPVKGDVTLTFLPLSFWGK-----KKNITKTFKINGSANFSFN--------DEEMKNV 302

Query: 286  ---------HFDVA----------VEEALTGRRQNNTGSVVFHKHKYKMDLIKSSEYFKP 326
                     + D++          V E++TG  +N + +V F +H Y ++    +   KP
Sbjct: 303  MDSSNGLSEYLDLSSPGPVEILTTVTESVTGISRNVSTNVFFKQHDYIIEFFDYTTVLKP 362

Query: 327  GLKYTAYMKLTHHDGTPVT---DNNNMVQVRHGFSYDE---------SKYEANQ---YKL 371
             L +TA +K+T  DG  +T     NN+V      +Y E          K EA Q   Y +
Sbjct: 363  SLNFTATVKVTRADGNQLTLEERRNNVVITVTQRNYTEYWSGSNSGNQKMEAVQKINYTV 422

Query: 372  DRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVN 431
             ++G  K+ +  P  E+ + L ++A +L  K   +  S  +SPS ++IQ     +N KV 
Sbjct: 423  PQSGTFKIEF--PILEDSSELQLKAYFLGSKSSMAVHSLFKSPSKTYIQLKTRDENIKVG 480

Query: 432  KDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKMSTVIRFLATYAMAPTAHVIVQ 491
               EL ++    LK +SY V+ RG ++        G + ST+       +  P A VIV 
Sbjct: 481  SPFELVVSGNKRLKELSYMVVSRGQLVAV------GKQNSTMFSLTPENSWTPKACVIVY 534

Query: 492  YVREDGEVVADGLDLELEGGLQNFVSANVSPDETEPGSNIQINLE-AKPNSYIGLLAVDQ 550
            Y+ +DGE+++D L + ++   +N +    S  + EP   + + +   +P+S +G++AVD+
Sbjct: 535  YIEDDGEIISDVLKIPVQLVFKNKIKLYWSKVKAEPSEKVSLRISVTQPDSIVGIVAVDK 594

Query: 551  KVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYPGSF-TAQATFEKAGAIVM 609
             V L+   NDI  E+V+ EL  Y+                Y G F  + A F++ G  V+
Sbjct: 595  SVNLMNASNDITMENVVHELELYNTG-------------YYLGMFMNSFAVFQECGLWVL 641

Query: 610  TNGYVHERNPWVYYKSLNDPPDDMLDGEEQLLSQVTTSV-TQLTVRKHFPETWLFQMEET 668
            T+  + +      Y +       M + E  ++     S+ +   VRKHFPETW++     
Sbjct: 642  TDANLTKDYIDGVYDNAEYAERFMEENEGHIVDIHDFSLGSSPHVRKHFPETWIWLDTNM 701

Query: 669  GFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRG 728
            G+         VPDSITSWV + F +    GLGL   P +L+ F+PFFI L+LPYSV+RG
Sbjct: 702  GYRIYQEFEVTVPDSITSWVATGFVISEDLGLGLTTTPVELQAFQPFFIFLNLPYSVIRG 761

Query: 729  EVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKKLTIKANS 788
            E  A+ + +FNYL       V +E   +FD    SNE++A          ++ L + +  
Sbjct: 762  EEFALEITIFNYLKDATEVKVIIEKSDKFDILMTSNEINATGH-------QQTLLVPSED 814

Query: 789  GSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTF 848
            G+T  F I P  LG I I VTA S  A D++   +LVK EG  +  +++I +DL  N+  
Sbjct: 815  GATVLFPIRPTHLGEIPITVTALSPTASDAVTQMILVKAEGIEKSYSQSILLDLTDNRLQ 874

Query: 849  SVNVTLDM--PKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIV 906
            S   TL    P N V GSE V+++A+GD+LGPSI  LA+LI+MP+GCGEQNM+NF PNI 
Sbjct: 875  STLKTLSFSFPPNTVTGSERVQITAIGDVLGPSINGLASLIRMPYGCGEQNMINFAPNIY 934

Query: 907  VLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAK 966
            +L+YL K  QLTD ++ KA  ++  GYQ+EL Y+R DGSFSAFG  DP+GSTWL+AFV +
Sbjct: 935  ILDYLTKKKQLTDNLKEKALSFMRQGYQRELLYQREDGSFSAFGNYDPSGSTWLSAFVLR 994

Query: 967  SFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAY 1023
             F +A  +  ID++V+     WL  +Q  NG F + G+V H+++QGG    + LTAY
Sbjct: 995  CFLEADPYIDIDQNVLHRTYTWLKGHQKSNGEFWDPGRVIHSELQGGNKSPVTLTAY 1051

Modulates negatively TGFB1 signaling in keratinocytes.
Homo sapiens (taxid: 9606)

>sp\|Q8R422\|CD109_MOUSE CD109 antigen OS=Mus musculus GN=Cd109 PE=2 SV=1	Back alignment and function description

>sp\|Q63041\|A1M_RAT Alpha-1-macroglobulin OS=Rattus norvegicus GN=A1m PE=1 SV=1	Back alignment and function description

>sp\|Q5R4N8\|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii GN=A2M PE=2 SV=1	Back alignment and function description

>sp\|P01023\|A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3	Back alignment and function description

>sp\|Q6IE52\|MUG2_RAT Murinoglobulin-2 OS=Rattus norvegicus GN=Mug2 PE=1 SV=1	Back alignment and function description

>sp\|P06238\|A2MG_RAT Alpha-2-macroglobulin OS=Rattus norvegicus GN=A2m PE=2 SV=2	Back alignment and function description

>sp\|Q6GQT1\|A2MP_MOUSE Alpha-2-macroglobulin-P OS=Mus musculus GN=A2mp PE=2 SV=2	Back alignment and function description

>sp\|P14046\|A1I3_RAT Alpha-1-inhibitor 3 OS=Rattus norvegicus GN=A1i3 PE=1 SV=1	Back alignment and function description

>sp\|P20740\|OVOS_CHICK Ovostatin OS=Gallus gallus PE=1 SV=3	Back alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Alignment Graph	Length	Definition	Q cover	H cover	Identity	E-value
Query		1397
328722177		2055	PREDICTED: CD109 antigen-like [Acyrthosi	0.726	0.493	0.644	0.0
340712511		1453	PREDICTED: c3 and PZP-like alpha-2-macro	0.728	0.700	0.572	0.0
332031265		1432	CD109 antigen [Acromyrmex echinatior]	0.730	0.712	0.564	0.0
242015286		1474	alpha-2-macroglobulin precursor, putativ	0.698	0.662	0.547	0.0
307210110		1382	CD109 antigen [Harpegnathos saltator]	0.680	0.687	0.592	0.0
307181016		1310	CD109 antigen [Camponotus floridanus]	0.646	0.689	0.601	0.0
321475103		1439	hypothetical protein DAPPUDRAFT_313404 [	0.698	0.678	0.526	0.0
331031264		1459	TEP isoform 2 [Pacifastacus leniusculus]	0.723	0.692	0.470	0.0
91083795		1475	PREDICTED: similar to tep3 [Tribolium ca	0.732	0.693	0.460	0.0
331031262		1507	TEP isoform 1 [Pacifastacus leniusculus]	0.721	0.668	0.446	0.0

>gi\|328722177\|ref\|XP_001944348.2\| PREDICTED: CD109 antigen-like [Acyrthosiphon pisum]	Back alignment and taxonomy information

 Score = 1380 bits (3572), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 667/1035 (64%), Positives = 840/1035 (81%), Gaps = 20/1035 (1%)

Query: 1    YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRI 60
            +YT+V PK+LRPN EYHVAVSTQ  +  T V V+VGGKQDSGG  +  Q + VDPFSTRI
Sbjct: 636  FYTIVGPKILRPNSEYHVAVSTQGTTSPTTVVVDVGGKQDSGGVLKVTQFVKVDPFSTRI 695

Query: 61   VKLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAI 120
            V+L+IGD+GPG YNLT +GSG L F+N+T L YVHKSYSVFIQ DKAIYKPG  V+FRAI
Sbjct: 696  VRLEIGDVGPGNYNLTARGSGGLEFFNTTTLEYVHKSYSVFIQTDKAIYKPGHKVQFRAI 755

Query: 121  VLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINV 180
            VLN HLKP+VTGAL+I+ITDG+GNR+K W+RALTTRGVFS++LQLS+SPVLGDWNI + V
Sbjct: 756  VLNYHLKPTVTGALDIYITDGQGNRVKHWSRALTTRGVFSSELQLSESPVLGDWNIVVTV 815

Query: 181  LDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAYP 240
            LDQ F K F VAEYVLPKFEV + VP H TFK S V  +++AKYTYGKPVKGEAT++ YP
Sbjct: 816  LDQVFHKSFLVAEYVLPKFEVTIEVPEHTTFKQSVVSATIHAKYTYGKPVKGEATVSVYP 875

Query: 241  TIFSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGRRQ 300
              +S +IQP++Q P+RKVVPI+GKTV++FDVVK+L L DE+ R I FDV VEEALTGR Q
Sbjct: 876  EYYSDLIQPIYQNPLRKVVPINGKTVVQFDVVKDLSLNDEFRRIITFDVTVEEALTGRSQ 935

Query: 301  NNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFSYD 360
            N + +V+FH HKYKMDLI++SEYFKPGLKYTA++K++HHDGTPV D+ N V+V HGFS++
Sbjct: 936  NTSANVMFHNHKYKMDLIRTSEYFKPGLKYTAFIKMSHHDGTPVYDDRNPVKVWHGFSHE 995

Query: 361  ESKYEANQYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQ 420
              K + +++ L RNG+I LVYYP  N +V  + IEAEYL+ +E  STI  + S SN+F+Q
Sbjct: 996  TEKLDESKHMLPRNGLIPLVYYPQINASV--IVIEAEYLNQREALSTILPAHSTSNTFMQ 1053

Query: 421  AALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVP-GNKMSTVIRFLAT 479
            A +LT+ P VNKDVE+++NST  L+YI+YQVLGRGDVI+A T+ +P   + + VIRFLAT
Sbjct: 1054 ATVLTERPTVNKDVEIQVNSTESLQYITYQVLGRGDVIVASTVQIPNAGQHTAVIRFLAT 1113

Query: 480  YAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANVSPDETEPGSNIQINLEAKP 539
            YAMAPTAHVIVQ+V++DGEVVAD +D+EL+G LQN+++ +VS DE EP +++ IN EAKP
Sbjct: 1114 YAMAPTAHVIVQFVKDDGEVVADAIDVELDGVLQNYINVDVSRDEVEPDTSVDINFEAKP 1173

Query: 540  NSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSK-LP-LVENLRER----YPG 593
            NSYIG+  +DQ VLLLKTGNDI  ++V+ ELR+YD  + S  +P L E+L  R    +PG
Sbjct: 1174 NSYIGVAGIDQSVLLLKTGNDISHDNVLDELRTYDNGEHSNYMPYLRESLDRRSMFWWPG 1233

Query: 594  SFTAQATFEKAGAIVMTNGYVHERNPWVYYKSLNDPPDDMLDGEEQL--LSQVTTSVTQL 651
            S+TA   F+K+GA ++TN +V++ NPWVYY+S      +++D +E +   S V+ + + +
Sbjct: 1234 SYTAHQAFDKSGATILTNAFVNDYNPWVYYRS------NVMDDQEMMPIPSTVSETSSSI 1287

Query: 652  TVRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRV 711
             VRK+FPETWL++  E+G DG+  +   VPD+ITSWV++AFSVDSLYGLGL+D PKKL+V
Sbjct: 1288 KVRKNFPETWLWESTESGQDGRASMKSTVPDTITSWVITAFSVDSLYGLGLLDSPKKLKV 1347

Query: 712  FRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLENVGQFDFADFSNEVDAAPQ 771
            FRPFFIS+DLPYSV RGE V+IPVVVFNYLS+D+ ADVTLEN+GQFDFAD SN+V  +  
Sbjct: 1348 FRPFFISVDLPYSVRRGEYVSIPVVVFNYLSKDVTADVTLENIGQFDFADTSNDVRDS-- 1405

Query: 772  PKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKLLVKPEGET 831
             K E+++RK LTIK+NSGS T+F+I  K+LGYI IK+TATS LAGD++E KLLVKPEGET
Sbjct: 1406 -KLELYKRKSLTIKSNSGSPTSFLIQTKDLGYISIKLTATSKLAGDAIEKKLLVKPEGET 1464

Query: 832  QYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPF 891
             YKNKAIFVDLRK   F  N+TL++P NIVP SE +E+ AVGD+LGPS  NLA+LI+MPF
Sbjct: 1465 IYKNKAIFVDLRKESLFEKNITLEIPSNIVPDSEFIEIGAVGDILGPSTMNLASLIQMPF 1524

Query: 892  GCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGT 951
            GCGEQNMLNFVPNIV+L+YLK T QLT A+E K+ +Y+ETGYQQELTYRR DGSFSAFG+
Sbjct: 1525 GCGEQNMLNFVPNIVILDYLKNTKQLTTAVETKSLKYMETGYQQELTYRRSDGSFSAFGS 1584

Query: 952  TDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGSFPEVGKVSHADMQ 1011
             D +GSTWLTA+V KSFRQA  +  I+E +I+E L WLS+NQA NGSFPEVG VSH+D+Q
Sbjct: 1585 ADASGSTWLTAYVVKSFRQAMPYIPIEEKIIIEGLQWLSNNQANNGSFPEVGYVSHSDIQ 1644

Query: 1012 GGAAKGLALTAYTLL 1026
            GG++KGLALTAYTL+
Sbjct: 1645 GGSSKGLALTAYTLI 1659

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi\|340712511\|ref\|XP_003394802.1\| PREDICTED: c3 and PZP-like alpha-2-macroglobulin domain-containing protein 8-like isoform 2 [Bombus terrestris]	Back alignment and taxonomy information

>gi\|332031265\|gb\|EGI70799.1\| CD109 antigen [Acromyrmex echinatior]	Back alignment and taxonomy information

>gi\|242015286\|ref\|XP_002428295.1\| alpha-2-macroglobulin precursor, putative [Pediculus humanus corporis] gi\|212512880\|gb\|EEB15557.1\| alpha-2-macroglobulin precursor, putative [Pediculus humanus corporis]	Back alignment and taxonomy information

>gi\|307210110\|gb\|EFN86807.1\| CD109 antigen [Harpegnathos saltator]	Back alignment and taxonomy information

>gi\|307181016\|gb\|EFN68790.1\| CD109 antigen [Camponotus floridanus]	Back alignment and taxonomy information

>gi\|321475103\|gb\|EFX86067.1\| hypothetical protein DAPPUDRAFT_313404 [Daphnia pulex]	Back alignment and taxonomy information

>gi\|331031264\|gb\|AEC50086.1\| TEP isoform 2 [Pacifastacus leniusculus]	Back alignment and taxonomy information

>gi\|91083795\|ref\|XP_972838.1\| PREDICTED: similar to tep3 [Tribolium castaneum] gi\|270008246\|gb\|EFA04694.1\| hypothetical protein TcasGA2_TC014664 [Tribolium castaneum]	Back alignment and taxonomy information

>gi\|331031262\|gb\|AEC50085.1\| TEP isoform 1 [Pacifastacus leniusculus]	Back alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Alignment graph	Length	Definition	Q cover	H cover	Identity	E-value
Query		1397
FB\|FBgn0041182		1420	Tep2 "Thioester-containing pro	0.750	0.738	0.369	3e-223
FB\|FBgn0041181		1469	Tep3 "Thioester-containing pro	0.407	0.387	0.359	8.1e-214
FB\|FBgn0041183		1354	Tep1 "Thioester-containing pro	0.420	0.434	0.363	7e-172
UNIPROTKB\|Q6YHK3		1445	CD109 "CD109 antigen" [Homo sa	0.710	0.687	0.339	2.2e-164
UNIPROTKB\|F1MPE1		1447	CD109 "Uncharacterized protein	0.704	0.680	0.341	1.4e-158
UNIPROTKB\|F1PM26		1445	CD109 "Uncharacterized protein	0.708	0.685	0.335	6.9e-158
UNIPROTKB\|K7GKY0		1449	CD109 "Uncharacterized protein	0.707	0.682	0.332	1.5e-155
UNIPROTKB\|F1RQH9		1450	CD109 "Uncharacterized protein	0.707	0.682	0.332	1.3e-154
MGI\|MGI:2445221		1442	Cd109 "CD109 antigen" [Mus mus	0.705	0.683	0.328	1.9e-148
UNIPROTKB\|F1NX20		1345	CD109 "Uncharacterized protein	0.662	0.687	0.340	3.6e-148

FB\|FBgn0041182 Tep2 "Thioester-containing protein 2" [Drosophila melanogaster (taxid:7227)]	Back alignment and assigned GO terms

 Score = 1777 (630.6 bits), Expect = 3.0e-223, Sum P(3) = 3.0e-223
 Identities = 408/1103 (36%), Positives = 624/1103 (56%)

Query:     2 YTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIV 61
             Y+VV P  LR N +Y+V VS       +Q+ V + G   S  E  TKQ+  + P ST+ V
Sbjct:    23 YSVVGPGTLRSNSKYNVVVSVHKADGPSQIKVSLNGP--SYNE--TKQI-ELPPMSTQNV 77

Query:    62 KLDIGDLGPGQYNLTVKGSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIV 121
             + ++  L  G YNL+ +G   + F NST L Y  K  SVF+Q DKA YKP DLV+FR + 
Sbjct:    78 EFEVPKLATGNYNLSAEGVSGVVFKNSTKLNYADKKPSVFVQTDKATYKPADLVQFRILF 137

Query:   122 LNSHLKPS-VTGALEIFITDGKGNRIKQWTRALTTRGVFSADLQLSKSPVLGDWNITINV 180
             L+ + +P+ +   + + I DG  NRIKQ +    T+GVFS +LQLS+ PVLG W I+++V
Sbjct:   138 LDENTRPAKIEKPISVIIIDGAQNRIKQLSDVKLTKGVFSGELQLSEQPVLGTWKISVSV 197

Query:   181 L-DQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITAY 239
               D + TK F V +YVLPKFEV V+ P      D  +  ++ AKYTYGKPVKG+AT++  
Sbjct:   198 DGDNRETKSFEVDKYVLPKFEVIVDTPKAVVIADKVIKATIRAKYTYGKPVKGKATVSME 257

Query:   240 PTI-FSGVIQPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEYERNIHFDVAVEEALTGR 298
              +  + G +         K + +DGK  +EFD++   Q   +Y   I     V E LTG 
Sbjct:   258 RSYGYFGDLNANGNKQ-EKTIDVDGKGHVEFDIIHWAQ-RGQYLPPIKLFAVVTEELTGN 315

Query:   299 RQNNTGSVVFHKHKYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDNNNMVQVRHGFS 358
             +QN T +VV H+ +Y ++  +  E+F+    +   + + + DG+PVT++   V++    S
Sbjct:   316 KQNATATVVLHQQRYSIEPYERPEHFEANKSFIYQVVVKNVDGSPVTNSAKNVKIGFDKS 375

Query:   359 YD-----ESKYEAN-QYKLDRNGMIKLVYYPPANENVTTLGIEAEYLDIKEWFSTISASE 412
             Y        K   N +  ++ NG+       P +++     I A +   +    +IS  E
Sbjct:   376 YSYFHEPSPKTRINFEAPVNENGIATFNVRLPDSDS-RYYRIFASFDGSENTIGSISKFE 434

Query:   413 -SP-SNSFIQAALLTQNPKVNKDVELEINSTAPLKYISYQVLGRGDVIMADTITVPGNKM 470
              +P S   ++  + T+ P++ + V  ++ S   L Y  Y ++ RG+VI++D + VP  + 
Sbjct:   435 PTPMSREPLKIQVNTKKPRLGEQVSFDVVSIEDLPYFVYTIVARGNVILSDYVDVPDGQK 494

Query:   471 STVIRFLATYAMAPTAHVIVQYVREDGEVVAXXXXXXXXXXXQNFVSANVSPDETEPGSN 530
             +  ++F  T++M P A + V YV  + ++              N +  + +P   +P   
Sbjct:   495 TYTVKFTPTFSMVPKATIYVYYV-VNNDLQFEEKTIDFEKEFSNSIDVS-APTNAKPSEE 552

Query:   531 IQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRER 590
             +++ ++   +S++GLL VDQ VLLLK+GND+ ++D+   L  Y +T T   P + N   R
Sbjct:   553 VKLRIKTDADSFVGLLGVDQSVLLLKSGNDLSQDDIFNSLNIY-QTST---PWM-NGYGR 607

Query:   591 YPGSFTAQATFEKA------GAIVMTNGYVHERNPWV----YYKSLNDPPDDM------- 633
             YPG  +   T   A      G +VM+  +   R+PW+    Y   +     D        
Sbjct:   608 YPGQTSGLVTLTNANYPYNTGPLVMSYVFEGSRHPWITRPRYRVGIRGDSGDRISFLSQS 667

Query:   634 LDGEEXXXXXXXXXXXXXXXRKHFPETWLFQMEETGFDGKVMVNEKVPDSITSWVLSAFS 693
             L+                  RK FPETW F  E  G + +  + +K+PD+ITSWV++ FS
Sbjct:   668 LNDRNLKEILLKQTPQRTTIRKEFPETWFF--ENVG-EEEFTLTKKIPDTITSWVVTGFS 724

Query:   694 VDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQDLVADVTLEN 753
             ++   G+ L   P K+RVF+PFF+S +LPYSV RGEV+AIPVV+FNYL + L ADV ++N
Sbjct:   725 LNPTSGIALTKNPSKIRVFQPFFVSTNLPYSVKRGEVIAIPVVIFNYLDKTLDADVVMDN 784

Query:   754 VGQ-FDFADFSNEVDAAPQPKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATS 812
               Q ++F + +NEV    +   EV R K++TI ANSG + +F+I PK +G+  +K+TATS
Sbjct:   785 SDQEYEFTEATNEV--LEKAIDEVRRVKRVTIPANSGKSVSFMIRPKNVGFTTLKITATS 842

Query:   813 NLAGDSMEGKLLVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAV 872
              LAGD++  KL V+PEG T ++N+A+F++L+     S ++  D+P  +VP SE +E S V
Sbjct:   843 ALAGDAIHQKLKVEPEGVTLFENRAVFINLKDQPEMSQSLDADIPNEVVPQSEFIEFSVV 902

Query:   873 GDLLGPSIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETG 932
             GDLLGP++ NL NL++MP+GCGEQNM+NFVPNI+VL+YL+ T +   ++E+KA ++LE G
Sbjct:   903 GDLLGPTLQNLDNLVRMPYGCGEQNMVNFVPNILVLKYLEVTGRKLPSVESKARKFLEIG 962

Query:   933 YQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSN 992
             YQ+ELTY+  DGS+SAFG +D +GSTWLTA+V +SF QA ++T ID  VI   L +L S 
Sbjct:   963 YQRELTYKHDDGSYSAFGKSDASGSTWLTAYVMRSFHQAGTYTDIDPKVITAGLDFLVSK 1022

Query:   993 QAVNGSFPEVGKV-SHADMQGGAAKGLALTAY----TLLPKKTRAVNMTATGSGFAVVYI 1047
             Q  +G FPEVGK+  +A+    A     L A+     L+PK   A+              
Sbjct:  1023 QKESGEFPEVGKLFDNANQNPLALTSFVLLAFFENHELIPKYQSAIKKAVRYVAEEADKT 1082

Query:  1048 SYQYNINVTGAWPMFTLDPQVDK 1070
               QY++ +          PQ +K
Sbjct:  1083 DDQYSLAIAAVALQLAKHPQSEK 1105

GO:0030414 "peptidase inhibitor activity" evidence=ISS

GO:0019731 "antibacterial humoral response" evidence=IDA

GO:0005615 "extracellular space" evidence=IEA

GO:0004866 "endopeptidase inhibitor activity" evidence=IEA

GO:0006911 "phagocytosis, engulfment" evidence=IMP

GO:0050829 "defense response to Gram-negative bacterium" evidence=IMP

FB\|FBgn0041181 Tep3 "Thioester-containing protein 3" [Drosophila melanogaster (taxid:7227)]	Back alignment and assigned GO terms

FB\|FBgn0041183 Tep1 "Thioester-containing protein 1" [Drosophila melanogaster (taxid:7227)]	Back alignment and assigned GO terms

UNIPROTKB\|Q6YHK3 CD109 "CD109 antigen" [Homo sapiens (taxid:9606)]	Back alignment and assigned GO terms

UNIPROTKB\|F1MPE1 CD109 "Uncharacterized protein" [Bos taurus (taxid:9913)]	Back alignment and assigned GO terms

UNIPROTKB\|F1PM26 CD109 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]	Back alignment and assigned GO terms

UNIPROTKB\|K7GKY0 CD109 "Uncharacterized protein" [Sus scrofa (taxid:9823)]	Back alignment and assigned GO terms

UNIPROTKB\|F1RQH9 CD109 "Uncharacterized protein" [Sus scrofa (taxid:9823)]	Back alignment and assigned GO terms

MGI\|MGI:2445221 Cd109 "CD109 antigen" [Mus musculus (taxid:10090)]	Back alignment and assigned GO terms

UNIPROTKB\|F1NX20 CD109 "Uncharacterized protein" [Gallus gallus (taxid:9031)]	Back alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8R422	CD109_MOUSE	No assigned EC number	0.3507	0.6485	0.6282	yes	N/A
Q6YHK3	CD109_HUMAN	No assigned EC number	0.3500	0.6936	0.6705	yes	N/A

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Alignment Graph	Length	Definition	E-value
Query		1397
cd02897		292	cd02897, A2M_2, Proteins similar to alpha2-macrogl	2e-79
cd02891		282	cd02891, A2M_like, Proteins similar to alpha2-macr	7e-59
cd02896		297	cd02896, complement_C3_C4_C5, Proteins similar to	2e-45
pfam07678		248	pfam07678, A2M_comp, A-macroglobulin complement co	9e-35
cd00688		300	cd00688, ISOPREN_C2_like, This group contains clas	6e-32
pfam07678		248	pfam07678, A2M_comp, A-macroglobulin complement co	8e-32
cd02897		292	cd02897, A2M_2, Proteins similar to alpha2-macrogl	2e-31
pfam00207		92	pfam00207, A2M, Alpha-2-macroglobulin family	1e-30
pfam07703		136	pfam07703, A2M_N_2, Alpha-2-macroglobulin family N	2e-27
cd02896		297	cd02896, complement_C3_C4_C5, Proteins similar to	2e-22
cd02891		282	cd02891, A2M_like, Proteins similar to alpha2-macr	6e-21
pfam01835		95	pfam01835, A2M_N, MG2 domain	2e-20
cd00688		300	cd00688, ISOPREN_C2_like, This group contains clas	2e-13
COG2373		1621	COG2373, COG2373, Large extracellular alpha-helica	4e-13
pfam10569		30	pfam10569, Thiol-ester_cl, Alpha-macro-globulin th	4e-13
pfam07677		90	pfam07677, A2M_recep, A-macroglobulin receptor	5e-11
pfam07677		90	pfam07677, A2M_recep, A-macroglobulin receptor	7e-11
COG2373		1621	COG2373, COG2373, Large extracellular alpha-helica	1e-10
pfam13249		112	pfam13249, Prenyltrans_2, Prenyltransferase-like	9e-06
pfam13249		112	pfam13249, Prenyltrans_2, Prenyltransferase-like	0.001

>gnl\|CDD\|239227 cd02897, A2M_2, Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

 Score =  263 bits (675), Expect = 2e-79
 Identities = 90/148 (60%), Positives = 112/148 (75%)

Query: 879  SIPNLANLIKMPFGCGEQNMLNFVPNIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELT 938
            ++ NL NL++MP+GCGEQNM+NF PNI VL+YLK T QLT  IE+KA  +L TGYQ++LT
Sbjct: 1    ALQNLDNLLRMPYGCGEQNMVNFAPNIYVLDYLKATGQLTPEIESKALGFLRTGYQRQLT 60

Query: 939  YRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVILEALAWLSSNQAVNGS 998
            Y+  DGS+SAFG +D +GSTWLTAFV KSF QA     IDE+V+ +AL WLSS+Q  NG 
Sbjct: 61   YKHSDGSYSAFGESDKSGSTWLTAFVLKSFAQARPFIYIDENVLQQALTWLSSHQKSNGC 120

Query: 999  FPEVGKVSHADMQGGAAKGLALTAYTLL 1026
            F EVG+V H  MQGG    +ALTAY L+
Sbjct: 121  FREVGRVFHKAMQGGVDDEVALTAYVLI 148

This group also contains the pregnancy zone protein (PZP). Alpha(2)-M and PZP are broadly specific proteinase inhibitors. Alpha (2)-M is a major carrier protein in serum. The structural thioester of alpha (2)-M, is involved in the immobilization and entrapment of proteases. PZP is a trace protein in the plasma of non-pregnant females and males which is elevated in pregnancy. Alpha (2)-M and PZ bind to placental protein-14 and may modulate its activity in T-cell growth and cytokine production contributing to fetal survival. It has been suggested that thioester bond cleavage promotes the binding of PZ and alpha (2)-M to the CD91 receptor clearing them from circulation. Length = 292

>gnl\|CDD\|239221 cd02891, A2M_like, Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>gnl\|CDD\|239226 cd02896, complement_C3_C4_C5, Proteins similar to C3, C4 and C5 of vertebrate complement	Back alignment and domain information

>gnl\|CDD\|219510 pfam07678, A2M_comp, A-macroglobulin complement component	Back alignment and domain information

>gnl\|CDD\|238362 cd00688, ISOPREN_C2_like, This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement	Back alignment and domain information

>gnl\|CDD\|219510 pfam07678, A2M_comp, A-macroglobulin complement component	Back alignment and domain information

>gnl\|CDD\|239227 cd02897, A2M_2, Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>gnl\|CDD\|215788 pfam00207, A2M, Alpha-2-macroglobulin family	Back alignment and domain information

>gnl\|CDD\|219528 pfam07703, A2M_N_2, Alpha-2-macroglobulin family N-terminal region	Back alignment and domain information

>gnl\|CDD\|239226 cd02896, complement_C3_C4_C5, Proteins similar to C3, C4 and C5 of vertebrate complement	Back alignment and domain information

>gnl\|CDD\|239221 cd02891, A2M_like, Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>gnl\|CDD\|216731 pfam01835, A2M_N, MG2 domain	Back alignment and domain information

>gnl\|CDD\|238362 cd00688, ISOPREN_C2_like, This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement	Back alignment and domain information

>gnl\|CDD\|225248 COG2373, COG2373, Large extracellular alpha-helical protein [General function prediction only]	Back alignment and domain information

>gnl\|CDD\|192631 pfam10569, Thiol-ester_cl, Alpha-macro-globulin thiol-ester bond-forming region	Back alignment and domain information

>gnl\|CDD\|203720 pfam07677, A2M_recep, A-macroglobulin receptor	Back alignment and domain information

>gnl\|CDD\|203720 pfam07677, A2M_recep, A-macroglobulin receptor	Back alignment and domain information

>gnl\|CDD\|225248 COG2373, COG2373, Large extracellular alpha-helical protein [General function prediction only]	Back alignment and domain information

>gnl\|CDD\|222007 pfam13249, Prenyltrans_2, Prenyltransferase-like	Back alignment and domain information

>gnl\|CDD\|222007 pfam13249, Prenyltrans_2, Prenyltransferase-like	Back alignment and domain information

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Alignment Graph	Length	Definition	Probability
Query		1397
KOG1366\|consensus		1436		100.0
COG2373		1621	Large extracellular alpha-helical protein [General	100.0
cd02896		297	complement_C3_C4_C5 Proteins similar to C3, C4 and	100.0
cd02897		292	A2M_2 Proteins similar to alpha2-macroglobulin (al	100.0
PF07678		246	A2M_comp: A-macroglobulin complement component; In	100.0
cd02891		282	A2M_like Proteins similar to alpha2-macroglobulin	100.0
PF07703		136	A2M_N_2: Alpha-2-macroglobulin family N-terminal r	99.9
PF00207		92	A2M: Alpha-2-macroglobulin family; InterPro: IPR00	99.89
PF07677		91	A2M_recep: A-macroglobulin receptor; InterPro: IPR	99.84
KOG1366\|consensus		1436		99.84
PF01835		99	A2M_N: MG2 domain; InterPro: IPR002890 The protein	99.8
cd00688		300	ISOPREN_C2_like This group contains class II terpe	99.71
cd02889		348	SQCY Squalene cyclase (SQCY) domain; found in clas	99.51
PF10569		31	Thiol-ester_cl: Alpha-macro-globulin thiol-ester b	99.36
COG2373		1621	Large extracellular alpha-helical protein [General	99.29
cd02892		634	SQCY_1 Squalene cyclase (SQCY) domain subgroup 1;	99.08
cd02896		297	complement_C3_C4_C5 Proteins similar to C3, C4 and	98.62
TIGR01507		635	hopene_cyclase squalene-hopene cyclase. SHC is an	98.55
PF07678		246	A2M_comp: A-macroglobulin complement component; In	98.32
cd02897		292	A2M_2 Proteins similar to alpha2-macroglobulin (al	97.95
TIGR03463		634	osq_cycl 2,3-oxidosqualene cyclase. This model ide	97.93
TIGR01787		621	squalene_cyclas squalene/oxidosqualene cyclases. T	97.87
PF05326		124	SVA: Seminal vesicle autoantigen (SVA); InterPro:	97.79
PLN03012		759	Camelliol C synthase	97.62
PLN02993		763	lupeol synthase	97.4
cd00688		300	ISOPREN_C2_like This group contains class II terpe	97.38
cd02889		348	SQCY Squalene cyclase (SQCY) domain; found in clas	97.31
cd02890		286	PTase Protein prenyltransferase (PTase) domain, be	97.01
PF13249		113	Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B	97.01
PF13249		113	Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B	96.91
PF07703		136	A2M_N_2: Alpha-2-macroglobulin family N-terminal r	96.67
cd02894		287	GGTase-II Geranylgeranyltransferase type II (GGTas	96.62
PRK14081		667	triple tyrosine motif-containing protein; Provisio	96.27
COG1470		513	Predicted membrane protein [Function unknown]	96.23
cd02893		299	FTase Protein farnesyltransferase (FTase)_like pro	96.1
cd02892		634	SQCY_1 Squalene cyclase (SQCY) domain subgroup 1;	95.91
TIGR03503		374	conserved hypothetical protein TIGR03503. This set	95.75
TIGR01507		635	hopene_cyclase squalene-hopene cyclase. SHC is an	95.72
COG1470		513	Predicted membrane protein [Function unknown]	95.59
PLN02710		439	farnesyltranstransferase subunit beta	95.51
PF13243		109	Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A	95.26
PLN02993		763	lupeol synthase	95.15
PLN03201		316	RAB geranylgeranyl transferase beta-subunit; Provi	95.06
TIGR01787		621	squalene_cyclas squalene/oxidosqualene cyclases. T	94.98
TIGR03463		634	osq_cycl 2,3-oxidosqualene cyclase. This model ide	94.84
PF10633		78	NPCBM_assoc: NPCBM-associated, NEW3 domain of alph	94.75
TIGR03503		374	conserved hypothetical protein TIGR03503. This set	93.76
PLN03012		759	Camelliol C synthase	93.66
PF10670		215	DUF4198: Domain of unknown function (DUF4198)	93.08
cd02890		286	PTase Protein prenyltransferase (PTase) domain, be	92.97
cd02894		287	GGTase-II Geranylgeranyltransferase type II (GGTas	92.38
cd02891		282	A2M_like Proteins similar to alpha2-macroglobulin	92.14
PRK13211		478	N-acetylglucosamine-binding protein A; Reviewed	92.11
PF01835		99	A2M_N: MG2 domain; InterPro: IPR002890 The protein	92.06
PF07919		554	Gryzun: Gryzun, putative trafficking through Golgi	91.86
PF07705		101	CARDB: CARDB; InterPro: IPR011635 The APHP (acidic	91.58
PF05753		181	TRAP_beta: Translocon-associated protein beta (TRA	91.1
COG5029		342	CAL1 Prenyltransferase, beta subunit [Posttranslat	90.48
cd02895		307	GGTase-I Geranylgeranyltransferase types I (GGTase	89.62
PF13115		86	YtkA: YtkA-like	89.1
PF10670		215	DUF4198: Domain of unknown function (DUF4198)	88.95
PLN03201		316	RAB geranylgeranyl transferase beta-subunit; Provi	88.26
cd02895		307	GGTase-I Geranylgeranyltransferase types I (GGTase	88.01
PLN02710		439	farnesyltranstransferase subunit beta	87.93
cd02893		299	FTase Protein farnesyltransferase (FTase)_like pro	87.86
smart00557		93	IG_FLMN Filamin-type immunoglobulin domains. These	87.48
COG5029		342	CAL1 Prenyltransferase, beta subunit [Posttranslat	87.47
KOG0367\|consensus		347		87.21
PF00207		92	A2M: Alpha-2-macroglobulin family; InterPro: IPR00	87.07
smart00634		92	BID_1 Bacterial Ig-like domain (group 1).	85.86
PF00630		101	Filamin: Filamin/ABP280 repeat; InterPro: IPR01786	84.28
KOG0366\|consensus		329		83.44
PF00927		107	Transglut_C: Transglutaminase family, C-terminal i	82.79
PF13243		109	Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A	81.2

>KOG1366\|consensus	Back alignment and domain information

Probab=100.00  E-value=6.8e-157  Score=1521.27  Aligned_cols=1180  Identities=35%  Similarity=0.543  Sum_probs=925.7

Q ss_pred             CEEEEeeCeeecCCeEEEEEEeecCCccEEEEEEEEeecCCCCeeEEeEEEEECCCceeEEEEEcCCCCC--ceeEEEEE
Q psy5522           1 YYTVVAPKVLRPNGEYHVAVSTQAVSEATQVSVEVGGKQDSGGEFRTKQLLSVDPFSTRIVKLDIGDLGP--GQYNLTVK   78 (1397)
Q Consensus         1 ~y~v~~P~~lr~g~~~~v~v~l~~~~~~v~v~v~L~~~~~~~~~~~~~~~~~~~~~~~~~~~f~vP~~~~--~~~~l~v~   78 (1397)
                      +|+|++|+++|+|+++++|.    ..+.+.+++++...+.+. .........-......|+.|++|....  ..|.....
T Consensus        22 ~y~v~~P~iir~~~~~~~~~----~~~~~~~~v~v~~~~~~~-~~~~~~~~~~~~~~~~~v~~~ip~~~~~~~~~~~~~~   96 (1436)
T KOG1366|consen   22 TYMLLAPSIIRVESPESLLE----VQSDVDVTVSVLLRPPSN-ARSIVTDTEGIFQDSSLVTFQIPSLPPNSAEYGRSEK   96 (1436)
T ss_pred             ceeeecceeEecCCCCceee----ecCCcceEEEEEecCccc-ccceeeccccccccccceeccccccCCCcceeEEeee
Confidence            59999999999999999444    344444444444332222 222333332334557899999996543  34788888


Q ss_pred             ecCceeeEeeEEEEEEecccEEEEEcCCCcccCCceeEEEEEEEcCCCccCCCcceEEEEECCCCCeEEeeeeeccCCce
Q psy5522          79 GSGSLNFYNSTGLVYVHKSYSVFIQLDKAIYKPGDLVRFRAIVLNSHLKPSVTGALEIFITDGKGNRIKQWTRALTTRGV  158 (1397)
Q Consensus        79 g~~~~~f~~~~~v~~~~~~~~vfIqTDKpIYkPGqtV~fRvv~ld~~l~P~~~~~~~v~I~DP~g~~I~qw~~~~~~~Gi  158 (1397)
                      | +++.|.+++.+++..+++++|||||||||+|||||+||+|+++.+++|. +  +.|+|+||+||+|+||+......|+
T Consensus        97 ~-~~l~f~~~~~l~~~~~~~~vfIqTDkpiY~pgqtV~~Rvv~~~~~~~~~-~--~~v~~~dp~~~~ikq~~~~~~~~gv  172 (1436)
T KOG1366|consen   97 G-PELEFENSTRLLFSQRRGSVFIQTDKPIYKPGQTVRYRVVTLNLKLKPF-K--VTVYIEDPEGNRIKQWLSVQSDGGV  172 (1436)
T ss_pred             c-ceEEEeeeeeeeeecccceEEEecCCCccCCCCEEEEEEEEeccccccc-c--ceEEEECCCCCchhhhhhccccCce
Confidence            8 8899999999999999999999999999999999999999999999995 4  9999999999999999999999999


Q ss_pred             eeeeeecCCCCCCeeEEEEEEEcCeEEEEEEEEeeecCCcEEEEEeCCCceEeeCCeEEEEEEEEEecCccccceEEEEE
Q psy5522         159 FSADLQLSKSPVLGDWNITINVLDQKFTKRFTVAEYVLPKFEVNVNVPPHATFKDSKVVISVNAKYTYGKPVKGEATITA  238 (1397)
Q Consensus       159 ~~~sf~L~~~~~lG~y~I~v~~~~~~~~~~F~VeEYvLPkFeV~v~~p~~i~~~~~~~~v~v~AkYtyGkPV~G~v~v~v  238 (1397)
                      ++++|+||++|.+|.|+|+|+..++..+..++|+|||||+|||.+++|+.+++. +++.++|||+|+|||||+|.+++++
T Consensus       173 ~~~~f~ls~~~~~G~w~I~v~~~~~~~~~~~~v~eyvlp~FeV~v~~~~~~~~~-~~~~~~v~a~y~ygkpV~g~~~v~~  251 (1436)
T KOG1366|consen  173 YSLSFQLSSEPILGDWKIRVQYKNGLQTKSSTVEEYVLPKFEVNVEPPSIITIN-KELEVTVCARYTYGKPVTGKATVSF  251 (1436)
T ss_pred             EEeeecccCCCcCCceEEEEEEcCCCccccceEEEEEecCceEeeecCcceeec-ceeEEEEeeeeecCCcccceEEEEE
Confidence            999999999999999999999988555555599999999999999999998887 9999999999999999999999999


Q ss_pred             EeccccCcc----ccccccceeEEeecCceEEEEEechhhhcccccc---ceEEEEEEEEEECCcceEEeeEEEEEEEEe
Q psy5522         239 YPTIFSGVI----QPLFQTPVRKVVPIDGKTVIEFDVVKELQLTDEY---ERNIHFDVAVEEALTGRRQNNTGSVVFHKH  311 (1397)
Q Consensus       239 ~~~~~~g~~----~~~~~~~~~~~~d~~G~~~~~~~~~~~~~~~~~~---~~~l~V~a~VtE~gTG~~~~~~~~i~i~~~  311 (1397)
                      ++....+..    ....|.....+...++|.....+... +......   .....+.+..+..-++...+.....+..+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~a~~~~i~~v~s~~~~~~~~~~~~~~~~~~~  330 (1436)
T KOG1366|consen  252 GLLDSDYKKCQPKIQSNCKNFEQQLNVEGCKVLNVDTQN-LQLYYNFEEGAEPVGITAVRSPFTTDIEETPLHLVPGGPA  330 (1436)
T ss_pred             ecccccccccccchhccccccccccceeeEEEEecCchh-heeehhhhccCcceeEEEEcccchhhhhhcceeecCCcce
Confidence            987432221    12234444555666677766655544 3332111   124555565565555666666667777788


Q ss_pred             eeEEEEEecCCcccCCCeEEEEEEEEccCCCccCCC-CceEEEEEeeeccccccceeeEeeCCCeeEEEE----------
Q psy5522         312 KYKMDLIKSSEYFKPGLKYTAYMKLTHHDGTPVTDN-NNMVQVRHGFSYDESKYEANQYKLDRNGMIKLV----------  380 (1397)
Q Consensus       312 ~~~i~f~~~~~~~kpG~p~~~~v~v~~~dG~P~~~~-~~~V~v~~~~~~~~~~~~~~~~ttd~~G~~~f~----------  380 (1397)
                      ..++.+.+....+|+|+|+.+++++.+.+|.|+... .....+.        .....+++++..+...+.          
T Consensus       331 ~~~v~v~~~~~~~k~gvp~~v~v~v~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (1436)
T KOG1366|consen  331 ELKVSVEDEDDSFKPGVPFTVQVKVVSKDGVPLDLDLPKEVQVD--------TSVQRPITTDRSKLVESNETMLATQNPS  402 (1436)
T ss_pred             eeeEEEeecCCcccCCcceEEEEEEecCCCcccccccccccccc--------ceEEEeeeccccccceeceeeccccCCc
Confidence            888999999999999999999999999999998732 1111111        111222223222222221          


Q ss_pred             -----EeC-CCCCceeEEEEEEEecCcceEEEEEEeecCCCCCeEEEEecCCCCCCCCeEEEEEEecC--------Ccce
Q psy5522         381 -----YYP-PANENVTTLGIEAEYLDIKEWFSTISASESPSNSFIQAALLTQNPKVNKDVELEINSTA--------PLKY  446 (1397)
Q Consensus       381 -----i~~-~~~~~~~~l~l~a~~~~~~~~~~~v~~~~S~s~s~L~i~~~~~~~~~G~~~~v~v~s~~--------~~~~  446 (1397)
                           ... +.+...  +....+..  ..+.+......+...++++.......+-++-...+.+.+..        ....
T Consensus       403 ~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  478 (1436)
T KOG1366|consen  403 LTLVRSLAPPSECPP--FLSDDETD--NRAVRLFRKTFNIVQSYIEKAKNSYKLYLQLNKGVKVLSGLGKRVTGILKSVS  478 (1436)
T ss_pred             ceeeEeeccCCCCcc--eEEeeecc--ccccccccccccccccccccccccceeeccccccceEEeeccceeeeEEEEec
Confidence                 111 111100  10000000  01111122222333344444333333333332222222110        0012


Q ss_pred             EEEEEEeCCeEEEE----EEEEecCCceeEEEEEeeCCCCCceeEEEEEEEecCCeEEEEeEEEEEcccccceeeEEecC
Q psy5522         447 ISYQVLGRGDVIMA----DTITVPGNKMSTVIRFLATYAMAPTAHVIVQYVREDGEVVADGLDLELEGGLQNFVSANVSP  522 (1397)
Q Consensus       447 ~~ylV~srG~Iv~~----~~~~~~~~~~~~~~~l~vt~~maP~a~l~vy~v~~~gevvads~~~~V~~~f~nkV~l~~s~  522 (1397)
                      ..|.++.++-++..    ..+..............++-.-.|.+++..+++.++|+++.|+..|.++.+++|+|.+.+++
T Consensus       479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~v~~~~~n~v~l~~~~  558 (1436)
T KOG1366|consen  479 PLYHFTYSGMIVFTITHGSHMVARVPTETVNDSACVKVLDKPVGLLVSFGIDSSGEVVGDSLKFKVEGDLKNKVALVANK  558 (1436)
T ss_pred             ceeEEeeccceeEEEEEeeEEecccceeeeccceeEEeeeeceeeEEEEEeccccccccceeEEEeeccccceEEEEEcc
Confidence            33444444444333    33322222345566667777777877888889999999999999999999999999999999


Q ss_pred             CCCCCCceEEEEEEecCCcEEEEEEEeeecccccCCCCCChhHHhHhccccCCCCCCCCccccccccccC----------
Q psy5522         523 DETEPGSNIQINLEAKPNSYIGLLAVDQKVLLLKTGNDIGKEDVMRELRSYDETDTSKLPLVENLRERYP----------  592 (1397)
Q Consensus       523 ~~~~Pg~~v~l~V~a~p~S~v~L~aVD~sVllL~~~~~lt~~~v~~~l~~y~~~~~~~~~~~~~~~~~~p----------  592 (1397)
                      ....||+++.+++...|+|+||+++||+|+++|+..|+++.+++...|..|+......    .. .+++|          
T Consensus       559 ~~~~~~~~~~~~~~~~~~s~vgl~~vd~s~~~m~~~n~~~~~~~~~~l~~~~~~~~~~----~~-~~~~~~~~~~~~~~~  633 (1436)
T KOG1366|consen  559 SAKEPGNNVALEVTDSPDSFVGLSAVDQSVLLMDAANDLTLEGVTFLLSEYDLTNQGG----KS-RGRNPGELVNKKKVT  633 (1436)
T ss_pred             cccCCCCcceeeecCCCceeecchhhhhhhhhcccccchhhhcceeeecccccccccc----Cc-cccCchhhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999998665311    00 11111          


Q ss_pred             CCcchhhHhhhcCeEEEecccccccCcccccccC---------CCCCCCcccchhhccccccccccccceecccCcceeE
Q psy5522         593 GSFTAQATFEKAGAIVMTNGYVHERNPWVYYKSL---------NDPPDDMLDGEEQLLSQVTTSVTQLTVRKHFPETWLF  663 (1397)
Q Consensus       593 ~~~d~~~~f~~~Gl~v~Tn~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~vR~~FpETwiW  663 (1397)
                      .+.+.+..++.+|+.+++|..+..+..+..+...         .....++..........+......++||++|||||||
T Consensus       634 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~VRk~FPEtWlw  713 (1436)
T KOG1366|consen  634 NAKYKYSTSKGDGLRFFCNPGIRSPSDASRRILVGRECSSVRRDLSGAGMPILAHALTNEDLSVPSKPRVRKHFPETWLW  713 (1436)
T ss_pred             cccchhhccccccceeeecCCccchhhhhhhccccccceeeeccccCCCcchheeecccccccCCCCcchhccCCcceee
Confidence            2356678888999999999888765443211000         0001111110000000011234678999999999999


Q ss_pred             EEEEeccCceEEEEEEcCCccccEEEEEEEEeCCCceeeeeCCeeEEEeeeEEEEecCCceeeeCCEEEEEEEEEcCCCc
Q psy5522         664 QMEETGFDGKVMVNEKVPDSITSWVLSAFSVDSLYGLGLMDMPKKLRVFRPFFISLDLPYSVMRGEVVAIPVVVFNYLSQ  743 (1397)
Q Consensus       664 ~~~~~~~~G~a~v~~tvPDtiT~W~~~Afa~s~~~G~G~a~~~~~l~vfkpffv~l~LPysv~rGE~~~l~~~VfNyl~~  743 (1397)
                      +.+.++.. ..++.+++||+||+|.++|||+|++.|+|++ ++.++++||||||+++|||||+|||+|.|+++||||+++
T Consensus       714 ~~~~v~~~-~~~~~v~~PDtiT~W~~~~f~ls~~~Gl~v~-~~~~l~~fQpfFi~l~lPySV~RgE~i~l~~tv~NYl~k  791 (1436)
T KOG1366|consen  714 DDVNVGRR-VKELTVTVPDTITTWVASGFSLSEDKGLGVA-PTTSLRVFQPFFIELNLPYSVRRGEQIALRVTVFNYLTK  791 (1436)
T ss_pred             eeEecCCc-eEEEEEEcCCccceEEEEEEEEcCCceeEec-CCceEEEeeceeEEecCceeEEeCcEeEEeEEEecccCc
Confidence            99999888 9999999999999999999999999999999 577799999999999999999999999999999999999


Q ss_pred             cEEEEEEEeecCCeeeeecCCCccCCCCCCcceeeeEEEEEeCCCeeEEEEEEEeceeeeEEEEEEEEeCCCCceeEEEE
Q psy5522         744 DLVADVTLENVGQFDFADFSNEVDAAPQPKFEVFRRKKLTIKANSGSTTTFVITPKELGYIGIKVTATSNLAGDSMEGKL  823 (1397)
Q Consensus       744 ~~~v~v~L~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~a~~~~tv~f~v~p~~lG~v~itV~A~~~~~~D~v~k~L  823 (1397)
                      +++|.|.+..+++++....+..+.....  .....+.....++++.+.+.|+|+|..+|.++++++|.+..++|+|+|+|
T Consensus       792 ~~~v~V~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~v~~~~s~~~~~~~v~p~~~g~~~~~~~~~t~~~~dav~k~l  869 (1436)
T KOG1366|consen  792 ELDVSVILLSSEDFCYDATSKANEQVGV--SQRSVQVSRVTPAQSGKLVYFPVRPGVIGLILVTISALTLLGGDAVHKTL  869 (1436)
T ss_pred             ceEEEEEEccCCCeeeecccccCccccc--ccceEEEEEEcccccceEEEEEeccccccccceEEEEeecCCCccEEEEE
Confidence            9999999999998887654433221110  01222334455699999999999999999999999999999999999999


Q ss_pred             EecCCCeeeEEEEEEEEecCCCceeEEEEEecCCCCcCCCCcEEEEEEEcccccCcccCcchhhccCCCchhhhhcccch
Q psy5522         824 LVKPEGETQYKNKAIFVDLRKNKTFSVNVTLDMPKNIVPGSEHVEVSAVGDLLGPSIPNLANLIKMPFGCGEQNMLNFVP  903 (1397)
Q Consensus       824 ~V~peG~~~~~t~s~~l~~~~~~~~~~~i~l~~P~~~v~gs~~~~vsv~gd~l~~~~~~l~~Ll~~P~GCgEQ~m~~~~p  903 (1397)
                      +|+|||++++..++.+||++.  +.++++++.+|+++|+||+++++++.||++|++++|+++|++||||||||||+.|+|
T Consensus       870 ~V~~eG~~~~~~~~~~i~l~~--~~~~~~~~~~p~~~V~~S~~~~~~~vgD~lGps~~~l~~Ll~lP~GcGEQnMi~faP  947 (1436)
T KOG1366|consen  870 LVEPEGITQERNFSVLIDLSV--SASKELSLGVPNDVVPGSERARISVVGDVLGPSMNNLSNLLRLPYGCGEQNMINFAP  947 (1436)
T ss_pred             EEeccCccceeeeeEEeccCC--CcCcceeecCCCCcCccccceeeEEEecccccChhhhHHhccCCCCcccceeecccc
Confidence            999999999999999999874  578999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhccccHHHHHHHHHHHHhccccceeeecCCCCccccCCCCCCCCcchhHHHHHHHHHccCCCccCHHHHH
Q psy5522         904 NIVVLEYLKKTYQLTDAIEAKASRYLETGYQQELTYRRPDGSFSAFGTTDPNGSTWLTAFVAKSFRQAASHTTIDESVIL  983 (1397)
Q Consensus       904 ~i~~l~yL~~~~~l~~~~~~~a~~~l~~gy~~~l~y~~~dGsfs~~~~~~~~~s~wlTAyvl~~~~~a~~~i~vd~~~~~  983 (1397)
                      |||+++||+.++|++++++++|+++|++||||+|+|+|+|||||+|+..+.++++||||||+++|.+|+++|.||+..+.
T Consensus       948 ni~v~~YL~~t~q~~~~~k~ka~~~l~~GyqrqL~yk~~DgSySaFg~~~~~~stWLtafvlr~f~~a~~~i~id~~~i~ 1027 (1436)
T KOG1366|consen  948 NIYVLKYLPKTNQLTPELKRKALKFLEQGYQRQLTYKRADGSYSAFGSSDRSGSTWLTAFVLRVFSQAKEYIFIDPNVIT 1027 (1436)
T ss_pred             hhhHHHHHhhhhccChhHHHHHHHHHHHHHHHHHhhhccCCChhhhcCCCCcccHHHHHHHHHHhhhccCceEecHHHHH
Confidence            99999999999999999999999999999999999999999999999977899999999999999999999999999999


Q ss_pred             HHHHHHHhcccCCCccccchHhHHHhhcCCCCccEEEEEEEEeccccceeEEEEeeeeEEEEEEEEEEeeccCCCCCcee
Q psy5522         984 EALAWLSSNQAVNGSFPEVGKVSHADMQGGAAKGLALTAYTLLPKKTRAVNMTATGSGFAVVYISYQYNINVTGAWPMFT 1063 (1397)
Q Consensus       984 ~~~~WL~~~q~~~G~F~stqdvl~al~~~~~~~~v~lt~~v~lp~~~~~~~v~~~G~G~~~~q~~~~Yn~~~~~~~~~f~ 1063 (1397)
                      ++++||.++|+.+|+|.+..+|++..+++++...+.+++....                                     
T Consensus      1028 ~a~~wl~~~Qk~~GsF~e~~~v~~~~~qg~l~~~~~l~~~~l~------------------------------------- 1070 (1436)
T KOG1366|consen 1028 QALNWLSQQQKENGSFKEVGEVLHNEMQGGLQDIVALTAIVLS------------------------------------- 1070 (1436)
T ss_pred             HHHHHHHHhhccCceEeccccccchhhhcCCCCcceeeeEeee-------------------------------------
Confidence            9999999999999999999999999999887666677776544                                     


Q ss_pred             eccccccCCCCCceEEEEEEeecCCCCccEEEEEecCCcccccCCCCchhhcccCceeEEEEeCCeEEEEEEeeecCCcc
Q psy5522        1064 LDPQVDKNSDSNHLQLSICSGFIGEGDSNMAVMEVSLPSGFTVDSDALPSLQVSQNVKRVETKNGNTMVVLYFAYHQVLP 1143 (1397)
Q Consensus      1064 l~v~~~~~~~~~~~~l~vc~~y~~~~~s~Mailev~l~SGf~~~~~~l~~l~~~~~i~~~e~~~~~~~v~lY~~~~~~~~ 1143 (1397)
                                                    +++++                             +               
T Consensus      1071 ------------------------------~~~~~-----------------------------~--------------- 1076 (1436)
T KOG1366|consen 1071 ------------------------------VILDV-----------------------------D--------------- 1076 (1436)
T ss_pred             ------------------------------eeccc-----------------------------h---------------
Confidence                                          55555                             1               


Q ss_pred             ceeeecccccccchhhHHHHHHHHHhhcCCC-CchHHHHHHHHHHhhCCCCchHHHHHHHhhcccccCC-cccccccCCC
Q psy5522        1144 WTLMHYLVSKYPRMNTINKAVDYIVKNLAGT-EDAYAIAICSYALHLAQHPVKDVAFNLLESKAHNEDG-KKWWKRAERP 1221 (1397)
Q Consensus      1144 ~~~~~~~~~~~~~~~~~~~a~~~l~~~~~~~-~~~y~~al~aYal~la~~~~~~~~~~~L~~~a~~~~~-~~~W~~~~~~ 1221 (1397)
                                   ...+.+|..|+++.++.. .++|+.|++||||.+++++.+..++.+|+.+|+.+++ ..||..+.+.
T Consensus      1077 -------------~~~~~~a~~~~~~~~~~~~~~~~~~a~~ayAl~l~~sp~a~~~~~~l~~~a~~~~d~~~~~~~~~~~ 1143 (1436)
T KOG1366|consen 1077 -------------NASIQKAVAYLEESLDSGSMDVYTVAITAYALQLAKSPQAAKALAKLKSLARVEGDRRYWWASALKA 1143 (1436)
T ss_pred             -------------hhHHHHHHHHHhhccCccccccchHHHHHHHHHhccCchHHHHHHhhhhhhcccCCceeeeeccccc
Confidence                         135788999999999865 7899999999999999999999988889999999877 5666665443


Q ss_pred             CCCCCCCCCCCCcccchhhHHHHHHhhccCCcccchhhhhhhhhcccCCCCccccccC----------------------
Q psy5522        1222 EDKKNPWAQVPNSVDVEMTSYALLSYLDRGLVEDTLPILTWLVTQQNDQGGFASTQMS---------------------- 1279 (1397)
Q Consensus      1222 ~~~~~~~~~~~~s~~vE~t~Y~lL~~~~~~~~~~a~~i~~Wl~~q~n~~Ggf~stQdT---------------------- 1279 (1397)
                      .+... |.+++++++|||||||||+++...+..++.||+|||++|||..|||+|||||                      
T Consensus      1144 ~~~~~-~~~q~~s~~VE~tsYaLL~~~~~~~~~~~~pivrWl~~qr~~~GGf~STQdTvvalqaLs~y~~~~~~~~~~~~ 1222 (1436)
T KOG1366|consen 1144 KNAVK-YSPQARSIDVETTAYALLAYLLLAQVDYALPIVRWLVEQRNALGGFSSTQDTVVALQALSEYAALSHTETLSLQ 1222 (1436)
T ss_pred             cCccc-CCCccchhhccchHHHHHHHHHhcccCcCchhHhhhhhhhcccCceeehHHHHHHHHHHHHhhhhcccceeEEE
Confidence            33212 5678899999999999999999888889999999999999999999999999                      


Q ss_pred             --------------------------------------------------------------------------------
Q psy5522        1280 -------------------------------------------------------------------------------- 1279 (1397)
Q Consensus      1280 -------------------------------------------------------------------------------- 1279 (1397)
                                                                                                      
T Consensus      1223 V~i~~~~~~~~~~~~~~~~~N~lllQ~~~~p~~~~~v~~ta~G~g~~~~q~~~~Ynv~~~~~~~~f~l~~~~~~~~~~~~ 1302 (1436)
T KOG1366|consen 1223 VTIQVPGKSSGTSQVDSTPNNLLLLQSVSLPSLHKTVCFTAKGQGCATVQISYTYNLLTPKSDPRFFLIVSTKPEPVEFD 1302 (1436)
T ss_pred             EEEEecccCCCceeeeccccchhhcceeecccCCCceEEEEecceeEEEEeeEEEeecCcccCCCceeeeeeccccccCc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------------CCcccccee
Q psy5522        1280 -----------------------------------------------------------------------KKELCPTVS 1288 (1397)
Q Consensus      1280 -----------------------------------------------------------------------~~~~c~~~~ 1288 (1397)
                                                                                             ++..|+.|+
T Consensus      1303 ~s~~~~~~~~~~~~~~~~~~SnMAIldVklpSGf~~~~~sl~~le~~~~v~~~~~~~~~~~v~~Y~D~v~~~~~~cv~F~ 1382 (1436)
T KOG1366|consen 1303 LSNIVVVYTTCCERTGSSGRSNMAILDVKLPSGFRADHESLGLLEQLEDVYRVEVENDHRRVLIYFDSVSGNETFCVRFE 1382 (1436)
T ss_pred             cccceEEEEEEEeecCCCCCCCceeeeeecccCcccChhhHHHhhccceEEEEEEecCCcceEEEeeccCCCCceEEEEE
Confidence                                                                                   567799999


Q ss_pred             ccccccccccCceeEEEeeccccchhheeeeccccccccccccCCCCCCcc
Q psy5522        1289 AFRTHKVAQQKPVPVSIYDYYDQSRRARMFYEPRVATLCDICEGEDCSKDT 1339 (1397)
Q Consensus      1289 ~~~~~~v~~~~p~~v~~ydyy~~~~~~~~~y~~~~~~~c~~c~~~~c~~~~ 1339 (1397)
                      |.|.++|+++|||+|+|||||+|+++|++||+++..++||+|++++|...|
T Consensus      1383 a~~~~~V~~~kpa~v~VYDYY~pee~~t~~Y~~~~~~~~~~c~~~~c~~~c 1433 (1436)
T KOG1366|consen 1383 AVQSFPVANLKPASVTVYDYYEPEEQATRFYNAESSSSCDVCEGAQCKCPC 1433 (1436)
T ss_pred             EEEEeehhccCCceEEEeeccCchhhhhhhhcccccchhhhcccccCCcCC
Confidence            999999999999999999999999999999999888899999999998755

>COG2373 Large extracellular alpha-helical protein [General function prediction only]	Back alignment and domain information

>cd02896 complement_C3_C4_C5 Proteins similar to C3, C4 and C5 of vertebrate complement	Back alignment and domain information

>cd02897 A2M_2 Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>PF07678 A2M_comp: A-macroglobulin complement component; InterPro: IPR011626 This domain covers the complement component region of the alpha-2-macroglobulin family	Back alignment and domain information

>cd02891 A2M_like Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>PF07703 A2M_N_2: Alpha-2-macroglobulin family N-terminal region; InterPro: IPR011625 This is a domain of the alpha-2-macroglobulin family	Back alignment and domain information

>PF00207 A2M: Alpha-2-macroglobulin family; InterPro: IPR001599 This entry contains serum complement C3 and C4 precursors and alpha-macrogrobulins	Back alignment and domain information

>PF07677 A2M_recep: A-macroglobulin receptor; InterPro: IPR009048 This entry represents the receptor-binding domain (RBD) of alpha-2-macroglobulin proteins	Back alignment and domain information

>KOG1366\|consensus	Back alignment and domain information

>PF01835 A2M_N: MG2 domain; InterPro: IPR002890 The proteinase-binding alpha-macroglobulins (A2M) [] are large glycoproteins found in the plasma of vertebrates, in the hemolymph of some invertebrates and in reptilian and avian egg white	Back alignment and domain information

>cd00688 ISOPREN_C2_like This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement	Back alignment and domain information

>cd02889 SQCY Squalene cyclase (SQCY) domain; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold	Back alignment and domain information

>PF10569 Thiol-ester_cl: Alpha-macro-globulin thiol-ester bond-forming region; InterPro: IPR019565 This entry contains serum complement C3 and C4 precursors and alpha-macrogrobulins	Back alignment and domain information

>COG2373 Large extracellular alpha-helical protein [General function prediction only]	Back alignment and domain information

>cd02892 SQCY_1 Squalene cyclase (SQCY) domain subgroup 1; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold	Back alignment and domain information

>cd02896 complement_C3_C4_C5 Proteins similar to C3, C4 and C5 of vertebrate complement	Back alignment and domain information

>TIGR01507 hopene_cyclase squalene-hopene cyclase	Back alignment and domain information

>PF07678 A2M_comp: A-macroglobulin complement component; InterPro: IPR011626 This domain covers the complement component region of the alpha-2-macroglobulin family	Back alignment and domain information

>cd02897 A2M_2 Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>TIGR03463 osq_cycl 2,3-oxidosqualene cyclase	Back alignment and domain information

>TIGR01787 squalene_cyclas squalene/oxidosqualene cyclases	Back alignment and domain information

>PF05326 SVA: Seminal vesicle autoantigen (SVA); InterPro: IPR007990 This family consists of seminal vesicle autoantigen and prolactin-inducible (PIP) proteins	Back alignment and domain information

>PLN03012 Camelliol C synthase	Back alignment and domain information

>PLN02993 lupeol synthase	Back alignment and domain information

>cd00688 ISOPREN_C2_like This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement	Back alignment and domain information

>cd02889 SQCY Squalene cyclase (SQCY) domain; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold	Back alignment and domain information

>cd02890 PTase Protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>PF13249 Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B 1O6Q_B 1H35_C 1H3A_C 1SQC_A 1UMP_A 1O6H_C 1O79_B 1GSZ_C 1H37_C	Back alignment and domain information

>PF13249 Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B 1O6Q_B 1H35_C 1H3A_C 1SQC_A 1UMP_A 1O6H_C 1O79_B 1GSZ_C 1H37_C	Back alignment and domain information

>PF07703 A2M_N_2: Alpha-2-macroglobulin family N-terminal region; InterPro: IPR011625 This is a domain of the alpha-2-macroglobulin family	Back alignment and domain information

>cd02894 GGTase-II Geranylgeranyltransferase type II (GGTase-II)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>PRK14081 triple tyrosine motif-containing protein; Provisional	Back alignment and domain information

>COG1470 Predicted membrane protein [Function unknown]	Back alignment and domain information

>cd02893 FTase Protein farnesyltransferase (FTase)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>cd02892 SQCY_1 Squalene cyclase (SQCY) domain subgroup 1; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold	Back alignment and domain information

>TIGR03503 conserved hypothetical protein TIGR03503	Back alignment and domain information

>TIGR01507 hopene_cyclase squalene-hopene cyclase	Back alignment and domain information

>COG1470 Predicted membrane protein [Function unknown]	Back alignment and domain information

>PLN02710 farnesyltranstransferase subunit beta	Back alignment and domain information

>PF13243 Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A 3SAE_A 3SDV_A 3SDT_A 3SDQ_A 3SDU_A	Back alignment and domain information

>PLN02993 lupeol synthase	Back alignment and domain information

>PLN03201 RAB geranylgeranyl transferase beta-subunit; Provisional	Back alignment and domain information

>TIGR01787 squalene_cyclas squalene/oxidosqualene cyclases	Back alignment and domain information

>TIGR03463 osq_cycl 2,3-oxidosqualene cyclase	Back alignment and domain information

>PF10633 NPCBM_assoc: NPCBM-associated, NEW3 domain of alpha-galactosidase; InterPro: IPR018905 This domain has been named NEW3, but its function is not known	Back alignment and domain information

>TIGR03503 conserved hypothetical protein TIGR03503	Back alignment and domain information

>PLN03012 Camelliol C synthase	Back alignment and domain information

>PF10670 DUF4198: Domain of unknown function (DUF4198)	Back alignment and domain information

>cd02890 PTase Protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>cd02894 GGTase-II Geranylgeranyltransferase type II (GGTase-II)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>cd02891 A2M_like Proteins similar to alpha2-macroglobulin (alpha (2)-M)	Back alignment and domain information

>PRK13211 N-acetylglucosamine-binding protein A; Reviewed	Back alignment and domain information

>PF01835 A2M_N: MG2 domain; InterPro: IPR002890 The proteinase-binding alpha-macroglobulins (A2M) [] are large glycoproteins found in the plasma of vertebrates, in the hemolymph of some invertebrates and in reptilian and avian egg white	Back alignment and domain information

>PF07919 Gryzun: Gryzun, putative trafficking through Golgi; InterPro: IPR012880 The proteins featured in this family are all hypothetical eukaryotic proteins of unknown function	Back alignment and domain information

>PF07705 CARDB: CARDB; InterPro: IPR011635 The APHP (acidic peptide-dependent hydrolases/peptidase) domain is found in a variety of different proteins	Back alignment and domain information

>PF05753 TRAP_beta: Translocon-associated protein beta (TRAPB); InterPro: IPR008856 This family consists of several eukaryotic translocon-associated protein beta (TRAPB) or signal sequence receptor beta subunit (SSR-beta) proteins	Back alignment and domain information

>COG5029 CAL1 Prenyltransferase, beta subunit [Posttranslational modification, protein turnover, chaperones]	Back alignment and domain information

>cd02895 GGTase-I Geranylgeranyltransferase types I (GGTase-I)-like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>PF13115 YtkA: YtkA-like	Back alignment and domain information

>PF10670 DUF4198: Domain of unknown function (DUF4198)	Back alignment and domain information

>PLN03201 RAB geranylgeranyl transferase beta-subunit; Provisional	Back alignment and domain information

>cd02895 GGTase-I Geranylgeranyltransferase types I (GGTase-I)-like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>PLN02710 farnesyltranstransferase subunit beta	Back alignment and domain information

>cd02893 FTase Protein farnesyltransferase (FTase)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold)	Back alignment and domain information

>smart00557 IG_FLMN Filamin-type immunoglobulin domains	Back alignment and domain information

>COG5029 CAL1 Prenyltransferase, beta subunit [Posttranslational modification, protein turnover, chaperones]	Back alignment and domain information

>KOG0367\|consensus	Back alignment and domain information

>PF00207 A2M: Alpha-2-macroglobulin family; InterPro: IPR001599 This entry contains serum complement C3 and C4 precursors and alpha-macrogrobulins	Back alignment and domain information

>smart00634 BID_1 Bacterial Ig-like domain (group 1)	Back alignment and domain information

>PF00630 Filamin: Filamin/ABP280 repeat; InterPro: IPR017868 The many different actin cross-linking proteins share a common architecture, consisting of a globular actin-binding domain and an extended rod	Back alignment and domain information

>KOG0366\|consensus	Back alignment and domain information

>PF00927 Transglut_C: Transglutaminase family, C-terminal ig like domain; InterPro: IPR008958 Synonym(s): Protein-glutamine gamma-glutamyltransferase, Fibrinoligase, TGase Transglutaminases catalyse the post-translational modification of proteins at glutamine residues, with formation of isopeptide bonds	Back alignment and domain information

>PF13243 Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A 3SAE_A 3SDV_A 3SDT_A 3SDQ_A 3SDU_A	Back alignment and domain information

Homologous Structure Templates